The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...
Following the beginning of the COVID-19 outbreak, lateral flow assays (LFAs)—the category of test strips in which the ...
Tunable DNA hairpin springs stretch millions of protein copies under piconewton tension, enabling bulk biochemical discovery ...
This quarter, MindWalk Holdings Corp. reported its third consecutive year-over-year revenue increase and advanced three ...
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2026 Earnings Call Transcript March 12, 2026 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.06086 EPS, expectations ...
Thank you for joining us today for MindWalk Holdings Corp.'s Third Quarter Fiscal Year 2026 Earnings Call. MindWalk trades on the NASDAQ under the ticker HYFT. Today's call will be led by our Chief ...
Targets $36 Billion TAM in Early Cancer Detection and MRD. Company in active discussions with global diagnostic leaders to accelerate commercialization. HENDERSON, Nev., March 18, ...
Many modern swine producers operate on thin margins where a 2% fluctuation in feed conversion ratio (FCR) or a slight dip in ...
Inhibrx Biosciences is a high-risk, catalyst-driven biotech, with valuation hinging on the clinical success of ozekibart and ...
Data highlights efficacy and safety of risankizumab in psoriatic disease, including high impact areas in psoriasis and long-term treatment of psoriatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results